Hansoh | Briefing, News, Analysis, Research, Data

Hansoh

Haosen Pharmaceuticals has developed into a modern and innovative pharmaceutical group integrating chemical and biological drug research

Haosen Pharmaceuticals has developed into a modern and innovative pharmaceutical group integrating chemical and biological drug research, pharmaceutical intermediates and API synthesis, preparation manufacturing and product sales. It is a national key high-tech enterprise, one of the top 20 of China's top 100 pharmaceutical enterprises, and one of the main R&D and production bases of anti-tumor and psychotropic drugs in China.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 1, 1995

HQ location

Jiangsu, China

Legal name

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Website

http://www.hansoh.cn

lhjtb@hspharm.com

Employees

8913

All
News
Analysis
Research

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Feb 07, 2023 12:11 PM · Healthcare

ForLong Biotech Nets Over CNY 100 Mn in Series A

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Feb 07, 2023 10:59 AM · Healthcare

CytoCan Corp. Nets CNY 10 Mn in Seed Round

Briefing Jan 30, 2023 10:44 AM · Healthcare

Levostar Completes Pre-A Financing Round to Further Invest in CGT

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Financials, Technology, Healthcare

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Jan 18, 2023 10:59 AM · Healthcare

BlissBio Nets Over CNY 100 Mn in Series B+

Briefing Sep 21, 2022 10:38 AM · Healthcare

Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round

Briefing Sep 16, 2022 11:10 PM · Healthcare

NaviSeed Nets Tens of millions of CNY in Angel Round

Briefing Sep 13, 2022 05:30 PM · Healthcare

Nuwacell Nets Hundreds of Mns of CNY in Series A

Healthcare

Reforgene Completes Pre-B Round Financing of CNY Hundreds of Millions

EqualOcean learned that Reforgene Medicine (瑞风生物) recently announced the completion of Pre-B round financing of CNY hundreds of millions.

May 04, 2023 02:05 PM

Healthcare

Joe Future Food Completes A+ Round Financing of CNY Tens of Million

Cell-Cultured Meat Leader, Joe Future Food (周子未来), completes A+ round financing of CNY tens of million.

Apr 28, 2023 05:13 PM

Briefing Aug 31, 2022 08:30 PM · Healthcare

Enitiatebio Nets One Hundred Million of CNY in Series A Round

Briefing Jun 28, 2022 09:56 AM · Healthcare

And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research

Briefing Jun 28, 2022 09:54 AM · Healthcare

Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China

Healthcare

Tripod, the New CRO, Completes C Round Financing of RMB Hundreds of Mn

Tripod Preclinical Research Laboratories Co., Ltd. (鼎泰集团) announced the completion of C round financing of RMB hundreds of million.

Apr 28, 2023 12:07 PM

Technology, Consumer Staples, Healthcare

HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D

Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.

Apr 23, 2023 12:20 PM

Briefing Jun 28, 2022 09:50 AM · Healthcare

It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results

Briefing Jun 28, 2022 09:37 AM · Healthcare

Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Jun 24, 2022 11:07 AM · Healthcare

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

EqualOcean Analysis